Washington: Patients of chronic hepatitis C, who drink three or more cups of coffee daily, have a 53 percent lower risk of liver disease progression than non-coffee drinkers, says a new study.
This study included 766 participants enrolled in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) trial who had hepatitis C-related cirrhosis and failed to respond to standard treatment of the anti-viral drugs peginterferon and ribavirin, according to an NCI release. Participants were seen every three months during the 3.8-year study period to assess clinical outcomes. Liver biopsies were also taken at 1.5 and 3.5 five years to determine the progression of liver disease. "Results from our study suggest that patients with high coffee intake had a lower risk of disease progression," said Freedman. These findings will appear in the November issue of Hepatology. Bureau Report
Shiv Sena hits out at Arvind Kejriwal, calls him `natakwala`
Kejriwal threatens to jail media for `promoting` Modi
I support `best CM` Mamata, not TMC: Anna
Is there a surge of support for Narendra Modi?